Assessment of the Strength of Evidence

Zhen Wang; Paolo Pianosi; Karina Keogh; Feras Zaiem; Mouaz Alsawas; Fares Alahdab; Jehad Almasri; Khaled Mohammed; Laura Larrea-Mantilla; Wigdan Farah; Lubna Daraz; Patricia Barrionuevo; Shalak Gunjal; Larry J Prokop; M Hassan Murad

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Wang Z, Pianosi P, Keogh K, et al. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec. (Comparative Effectiveness Reviews, No. 197.)

Cover of The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management

The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet].

Show details

Contents

< Prev Next >

Appendix HAssessment of the Strength of Evidence

Table H.1

Assessment of the Strength of Evidence KQ1a.

Table H.2

Assessment of the Strength of Evidence KQ1b. Narrative Evaluation.

Table H.3

Assessment of the Strength of Evidence KQ1c.

Table H.4

Assessment of the Strength of Evidence KQ1e. Narrative Evaluation.

Bookshelf ID: NBK487486

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Wang Z, Pianosi P, Keogh K, et al. The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec. (Comparative Effectiveness Reviews, No. 197.) Appendix H, Assessment of the Strength of Evidence.
PDF version of this title (5.2M)